Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Microsoft is in exclusive negotiations with Chevron and activist investor Engine No. 1 on a proposed natural gas-fired power complex in West Texas intended to supply electricity to a data center campus. The facility is expected to cost about $7 billion and initially produce approximately 2,500 megawatts. The discussions occur as major cloud provide…
Melissa Marano Thompson, a director at ArrowMark Financial Corp (NASDAQ: BANX), purchased 1,500 common shares on March 27, 2026, at $18.765 per share, according to a Form 4 filing. The purchase totaled $28,147. ArrowMark is concurrently conducting a rights offering for up to 2,604,156 new common shares, with shareholders of record as of January 22 …
Strawberry Fields REIT director Stanford Gertz purchased 1,395 shares of the company’s common stock on March 18, 2026, paying $12.52 per share for a total of $17,465. The buy was conducted at a price above the current trading level of $11.90 and follows company announcements that include a $0.16 cash dividend for Q1 2026 and an increase in compensa…
Edgewise Therapeutics Chief Medical Officer Joanne M. Donovan sold 21,338 shares of common stock on March 31, 2026, for roughly $685,308 at prices between $32.00 and $32.35 under a Rule 10b5-1 plan. The transaction occurred as the stock traded near a 52-week high of $32.80 after a 94% six-month gain. Donovan simultaneously exercised options to buy …
President Donald Trump told reporters the United States could end its military campaign against Iran within two to three weeks and said Tehran did not need to negotiate a deal for strikes to stop. Senior U.S. officials gave differing public signals on whether diplomacy was a prerequisite to an end to hostilities, while Iran’s Revolutionary Guards a…
The U.S. Commodity Futures Trading Commission will prioritize enforcement against potential insider trading in prediction markets and manipulative conduct in energy markets, the agency's new enforcement director said in his first public remarks since taking the post. The CFTC will also concentrate on spoofing and willful violations of anti-money-la…
The Low Pay Commission has proposed that Britain’s national minimum wage may need to increase by about 3.7% in 2027 to keep pace with expected average earnings growth, projecting a central rate of 13.18 pounds an hour while opening an annual consultation with employers, unions and the public. The projection is provisional and the commission said th…
A three-judge circuit court panel in Wisconsin dismissed a lawsuit brought by Democratic voters seeking to overturn the state's congressional map, ruling that the authority to determine whether the maps must be redrawn rests with the Wisconsin Supreme Court. The decision can be appealed, but it is uncertain whether the state Supreme Court would act…
A federal judge in Texas refused to approve an IRS-crafted settlement that would have permitted churches and other houses of worship to endorse political candidates without risking loss of tax-exempt status. U.S. District Judge J. Campbell Barker found the Tax Anti-Injunction Act barred his review and signing of a consent judgment between the IRS, …
TG Therapeutics' BRIUMVI continues to drive outsized top-line growth, management is leaning into commercial expansion and awareness campaigns, and the stock trades at a reasonable P/E for a growth-to-profit story. We recommend a tactical long with a $33.20 entry, $46.48 target and $29.00 stop, horizon ~180 trading days.
Platinum Equity sold 1,348,314 shares of Ingram Micro Holding Corp on March 30, 2026, at $21.36 per share for a total of $28,799,987. The stake was transacted through a chain of affiliated vehicles controlled by Tom Gores. After the sale, Platinum Equity and related entities continue to beneficially own 197,104,541 shares. Separately, Ingram Holdco…
Adaptive Biotechnologies Corp. executive Julie Rubinstein sold 57,180 shares of common stock between March 27 and March 31, 2026, generating about $751,302 in proceeds from prices between $12.07 and $13.87. The transactions accompanied the exercise of stock options that produced 44,166 shares at $7.27 each. The trades were carried out under a Rule …
Palladyne AI Corp (NASDAQ: PDYN) Chief Financial Officer Trevor Thatcher disposed of 3,030 shares on March 30, 2026 to satisfy income tax obligations tied to recently vested restricted stock units. The sale, executed across multiple trades at prices between $5.295 and $5.6301 for an average of $5.5463, totaled $16,805. After the transactions, Thatc…
Deere & Company is showing fresh positive signals: renewed analyst optimism after February results, dividend support, and industry tailwinds in agricultural robots and autonomous construction equipment. The stock pulled back from its 52-week high but is trading on solid fundamentals - PE ~31, ROE ~18%, and $3.58B of free cash flow. This trade targe…
Palladyne AI Corp. (OTC: PDYN) Chief Legal Officer Stephen Sonne reported the sale of 3,471 common shares on March 30, 2026, in a Form 4 filing with the SEC. The shares were sold to satisfy income tax liabilities tied to vested restricted stock units and fetched a weighted average price of $5.5463, for total proceeds of $19,251. The stock has since…
Palladyne AI Corp. Chief Technology Officer Denis Garagic sold 15,149 shares of common stock on March 30, 2026, raising $84,020 at a weighted average price of $5.5463 to meet income tax liabilities tied to vested restricted stock units. The company has reported large year-over-year revenue gains for Q4 2025 and secured defense contracts, while its …
BFI Co., LLC, a roughly 10% holder of Phibro Animal Health Corp (NASDAQ: PAHC), sold 14,080 Class A shares on March 30-31, 2026 for about $756,833 under a Rule 10b5-1 plan adopted in December 2025. After the transactions, BFI Co. directly holds 38,120 shares. Jack Bendheim, Phibro’s President and CEO, exercises voting and dispositive power over BFI…
Kimberly D. Campos, chief investment officer and chief accounting officer at Universal Insurance Holdings (NASDAQ: UVE), sold 946 shares on March 31, 2026, for $34.12 per share, totaling $32,277. The Form 4 filing also reports an option exercise for 1,251 shares at a $0 strike and the withholding of 305 shares on March 27, 2026, to satisfy tax obli…
A Republican senator plans to introduce legislation next month to expand U.S. measures barring Chinese automakers from the American market, seeking to close avenues beyond imports and calling on other countries to adopt similar rules. The Biden administration has already issued a regulation that will effectively stop Chinese passenger vehicle sales…
The Department of Homeland Security has put on hold plans to repurpose large warehouses for immigrant detention while newly appointed Secretary Markwayne Mullin reviews a controversial program initiated under Kristi Noem. Documents show the prior plan called for $38.3 billion in spending by year-end to establish detention centers to hold and proces…
Daxor CORP Chief Financial Officer Robert J. Michel purchased 1,000 shares of company stock for $9.90 per share on March 31, 2026, bringing his direct holding to 21,050 shares. The transaction coincides with a stock price trading below the purchase level, recent operating revenue growth, an increase in net assets and a completed registered direct o…
President Trump told reporters that U.S. military forces will withdraw from Iran within two to three weeks, saying the objective of eliminating the country's nuclear threat has been met. He confirmed ongoing operations, including strikes on missile-making facilities, and said the United States does not require a separate agreement with Iran to depa…
Meta ($META) looks vulnerable despite recent strength. Fundamentals are solid but priced for perfection: P/E ~22.8, P/S ~6.8 and stretched technicals leave room for a re-test of the low $400s if ad growth disappoints or Reality Labs costs re-emerge. This is a mid-term (45 trading days) actionable short with defined entry, stop and target sized for …
President Donald Trump indicated he will likely appear in person at the U.S. Supreme Court on Wednesday for oral arguments over his directive aimed at restricting birthright citizenship. The case confronts whether his executive order, which instructed federal agencies not to recognize U.S. citizenship for children born on U.S. soil to parents who a…
C3.ai director Snabe Jim H. sold 10,000 Class A shares for $8.08 apiece and, on the same day, bought 10,000 Class A shares at $7.73, leaving him with a stated direct holding of 385,000 shares and an indirect stake of 28,000 through BJHS Invest ApS. The transactions come amid a difficult quarter for the enterprise AI company - fiscal Q3 results mate…
